Literature DB >> 28818984

Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts.

Daniel S Albrecht1,2, Marc D Normandin1, Sergey Shcherbinin3, Dustin W Wooten2, Adam J Schwarz3, Nicole R Zürcher1, Vanessa N Barth3, Nicolas J Guehl2, Oluwaseun Akeju4, Nazem Atassi5, Mattia Veronese6, Federico Turkheimer6, Jacob M Hooker1, Marco L Loggia7.   

Abstract

The translocator protein (TSPO) is a commonly used imaging target to investigate neuroinflammation. Although TSPO imaging demonstrates great promise, its signal exhibits substantial interindividual variability, which needs to be accounted for to uncover group effects that are truly reflective of neuroimmune activation. Recent evidence suggests that relative metrics computed using pseudoreference approaches can minimize within-group variability and increase sensitivity to detect physiologically meaningful group differences. Here, we evaluated various ratio approaches for TSPO imaging and compared them with standard kinetic modeling techniques, analyzing 2 different disease cohorts. Patients with chronic low back pain (cLBP) or amyotrophic lateral sclerosis (ALS) and matching healthy controls received 11C-PBR28 PET scans. The occipital cortex, cerebellum and whole brain were first evaluated as candidate pseudoreference regions by testing for the absence of group differences in SUV and distribution volume (VT) estimated with an arterial input function. The SUV from target regions (cLBP study, thalamus; ALS study, precentral gyrus) was normalized with the SUV from candidate pseudoreference regions (i.e., occipital cortex, cerebellum, and whole brain) to obtain SUVRoccip, SUVRcereb, and SUVRWB The sensitivity to detect group differences in target regions was compared using various SUVR approaches, as well as distribution volume ratio (DVR) estimated with (blDVR) or without arterial input function (refDVR), and VT Additional voxelwise SUVR group analyses were performed. We observed no significant group differences in pseudoreference VT or SUV, excepting whole-brain VT, which was higher in cLBP patients than controls. Target VT elevations in patients (P = 0.028 and 0.051 in cLBP and ALS, respectively) were similarly detected by SUVRoccip and SUVRWB, and by refDVR and blDVR (less reliably by SUVRcereb). In voxelwise analyses, SUVRoccip, but not SUVRcereb, identified regional group differences initially observed with SUVRWB, and in additional areas suspected to be affected in the pathology examined. All ratio metrics were highly cross-correlated, but generally were not associated with VT. Although important caveats need to be considered when using relative metrics, ratio analyses appear to be similarly sensitive to detect pathology-related group differences in 11C-PBR28 signal as classic kinetic modeling techniques. The occipital cortex may be a suitable pseudoreference region, at least for the populations evaluated, pending further validation in larger cohorts.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  astrocytes; human; microglia; neuroimmunology; neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 28818984      PMCID: PMC5750517          DOI: 10.2967/jnumed.116.178335

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  43 in total

1.  Activation of astrocytes in the anterior cingulate cortex contributes to the affective component of pain in an inflammatory pain model.

Authors:  Feng-Li Chen; Yu-Lin Dong; Zhi-Jun Zhang; De-Li Cao; Jie Xu; Jie Hui; Li Zhu; Yong-Jing Gao
Journal:  Brain Res Bull       Date:  2011-10-08       Impact factor: 4.077

2.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

3.  Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain.

Authors:  Christina S Hines; Masahiro Fujita; Sami S Zoghbi; Jin Su Kim; Zenaide Quezado; Peter Herscovitch; Ning Miao; Maria D Ferraris Araneta; Cheryl Morse; Victor W Pike; Julia Labovsky; Robert B Innis
Journal:  J Nucl Med       Date:  2012-11-12       Impact factor: 10.057

4.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

5.  Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study.

Authors:  Jennifer M Coughlin; Yuchuan Wang; Cynthia A Munro; Shuangchao Ma; Chen Yue; Shaojie Chen; Raag Airan; Pearl K Kim; Ashley V Adams; Cinthya Garcia; Cecilia Higgs; Haris I Sair; Akira Sawa; Gwenn Smith; Constantine G Lyketsos; Brian Caffo; Michael Kassiou; Tomas R Guilarte; Martin G Pomper
Journal:  Neurobiol Dis       Date:  2014-11-07       Impact factor: 5.996

6.  Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome.

Authors:  Luis Del Valle; Robert J Schwartzman; Guillermo Alexander
Journal:  Brain Behav Immun       Date:  2008-08-26       Impact factor: 7.217

7.  Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain.

Authors:  Lorenzo Di Cesare Mannelli; Alessandra Pacini; Laura Bonaccini; Matteo Zanardelli; Tommaso Mello; Carla Ghelardini
Journal:  J Pain       Date:  2013-10-14       Impact factor: 5.820

8.  Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Jon B Toledo; Vivianna M Van Deerlin; Lauren Elman; Leo McCluskey; Virginia M-Y Lee; John Q Trojanowski
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema.

Authors:  Masahiro Fujita; Siddhartha Mahanty; Sami S Zoghbi; Maria Desiree Ferraris Araneta; Jinsoo Hong; Victor W Pike; Robert B Innis; Theodore E Nash
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

10.  Gray matter alterations in chronic pain: A network-oriented meta-analytic approach.

Authors:  Franco Cauda; Sara Palermo; Tommaso Costa; Riccardo Torta; Sergio Duca; Ugo Vercelli; Giuliano Geminiani; Diana M E Torta
Journal:  Neuroimage Clin       Date:  2014-04-16       Impact factor: 4.881

View more
  17 in total

1.  Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.

Authors:  Daniel S Albrecht; Anton Forsberg; Angelica Sandström; Courtney Bergan; Diana Kadetoff; Ekaterina Protsenko; Jon Lampa; Yvonne C Lee; Caroline Olgart Höglund; Ciprian Catana; Simon Cervenka; Oluwaseun Akeju; Mats Lekander; George Cohen; Christer Halldin; Norman Taylor; Minhae Kim; Jacob M Hooker; Robert R Edwards; Vitaly Napadow; Eva Kosek; Marco L Loggia
Journal:  Brain Behav Immun       Date:  2018-09-14       Impact factor: 7.217

2.  In-vivo imaging of neuroinflammation in veterans with Gulf War illness.

Authors:  Zeynab Alshelh; Daniel S Albrecht; Courtney Bergan; Oluwaseun Akeju; Daniel J Clauw; Lisa Conboy; Robert R Edwards; Minhae Kim; Yvonne C Lee; Ekaterina Protsenko; Vitaly Napadow; Kimberly Sullivan; Marco L Loggia
Journal:  Brain Behav Immun       Date:  2020-02-04       Impact factor: 7.217

Review 3.  PET imaging of neuroinflammation in neurological disorders.

Authors:  William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis
Journal:  Lancet Neurol       Date:  2020-11       Impact factor: 44.182

4.  [11C]PBR28 MR-PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder.

Authors:  N R Zürcher; M L Loggia; J E Mullett; C Tseng; A Bhanot; L Richey; B G Hightower; C Wu; A J Parmar; R I Butterfield; J M Dubois; D B Chonde; D Izquierdo-Garcia; H Y Wey; C Catana; N Hadjikhani; C J McDougle; J M Hooker
Journal:  Mol Psychiatry       Date:  2020-02-19       Impact factor: 15.992

5.  Magnetic resonance imaging of neuroinflammation in chronic pain: a role for astrogliosis?

Authors:  Changjin Jung; Eric Ichesco; Eva-Maria Ratai; Ramon Gilberto Gonzalez; Tricia Burdo; Marco L Loggia; Richard E Harris; Vitaly Napadow
Journal:  Pain       Date:  2020-07       Impact factor: 7.926

6.  Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.

Authors:  Donatienne Van Weehaeghe; Suma Babu; Joke De Vocht; Nicole R Zürcher; Sheena Chew; Chieh-En J Tseng; Marco L Loggia; Michel Koole; Ahmadreza Rezaei; Georg Schramm; Philip Van Damme; Jacob M Hooker; Koen Van Laere; Nazem Atassi
Journal:  J Nucl Med       Date:  2020-03-13       Impact factor: 11.082

7.  Neuroimmune signatures in chronic low back pain subtypes.

Authors:  Zeynab Alshelh; Ludovica Brusaferri; Atreyi Saha; Erin Morrissey; Paulina Knight; Minhae Kim; Yi Zhang; Jacob M Hooker; Daniel Albrecht; Angel Torrado-Carvajal; Michael S Placzek; Oluwaseun Akeju; Julie Price; Robert R Edwards; Jeungchan Lee; Roberta Sclocco; Ciprian Catana; Vitaly Napadow; Marco L Loggia
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

8.  Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function.

Authors:  Mattia Veronese; Marcello Tuosto; Tiago Reis Marques; Oliver Howes; Belen Pascual; Meixiang Yu; Joseph C Masdeu; Federico Turkheimer; Alessandra Bertoldo; Paolo Zanotti-Fregonara
Journal:  Mol Imaging Biol       Date:  2021-01-21       Impact factor: 3.488

9.  [11C]PBR28 radiotracer kinetics are not driven by alterations in cerebral blood flow.

Authors:  Christin Y Sander; Stefano Bovo; Angel Torrado-Carvajal; Daniel Albrecht; Hongping Deng; Vitaly Napadow; Julie C Price; Jacob M Hooker; Marco L Loggia
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

Review 10.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.